Clinical trials
PARKINSON DISEASE (Disorder) clinical trials
Below are recruiting parkinson disease (disorder) clinical trials, each written for real people, not researchers. We’re tracking 496 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07378722Recruiting
Personalized music therapy for balance in Parkinson's disease
This study tests whether listening to personalized music can help improve balance and walking in people with Parkinson's. If you have mild balance issues and are between 45 and 55, this trial might be a good fit.
Lahore, Punjab ProvinceAges 45–55 - NCT05444907Recruiting
Testing treatment response in DBS-related mania in Parkinson’s
This study is looking at people with Parkinson’s who developed mania (a high-energy mood episode) after deep brain stimulation (DBS) was turned on or its settings were changed. It may help doctors better understand why this happens and how to manage it safely.
LisbonAges 18 years+ - NCT07322887RecruitingPhase 2
Study of sul-238 for early untreated parkinson's disease
This study tests whether an experimental medicine called SUL-238 can improve energy levels in the brain cells of people with early, untreated Parkinson's. It uses a special type of MRI to see if the medicine affects brain energy.
GroningenAges 40 years+ - NCT07310147Recruiting
Online ACT therapy for young-onset Parkinson’s
This trial tests an online program based on Acceptance and Commitment Therapy (ACT) to help people with young-onset Parkinson’s disease cope better with life challenges. It aims to improve emotional well-being and quality of mind.
CoimbraAges 21–65 - NCT05773885Recruiting
Telerehab sessions for people with Parkinson’s disease
This study tests whether rehab delivered through the internet (“telerehabilitation”) can help people with Parkinson’s disease. You may be able to do therapy from home, while the team monitors your function during the study.
Cassino, FrosinoneAges 30–80 - NCT07244640Recruiting
Detecting Parkinson's through eye scans
This study uses a special eye camera to see if early signs of Parkinson's and similar movement disorders can be spotted in the retina. It may help doctors diagnose these conditions sooner and more easily.
Hangzhou, ZhejiangAges 40–80 - NCT07216066RecruitingPhase 1
Study of ALN-SNCA for early Parkinson's disease
This trial tests a new experimental drug called ALN-SNCA, given as an injection into the spinal fluid, for people with early Parkinson's disease. The goal is to see if it is safe and well-tolerated.
Ottawa, OntarioAges 50–80 - NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Birmingham, AlabamaAges 50–85 - NCT07170475RecruitingPhase 1
Study of febuxostat and inosine for Parkinson's disease
This trial tests whether a combination of two supplements, febuxostat and inosine, can help people with Parkinson's disease. It aims to see if this treatment is safe and may improve symptoms.
Toyoake, Aichi-kenAges 18–80 - NCT07105787Recruiting
Parkinson's exercise study: Tel Aviv and Bologna
This trial tests whether a specific exercise program can improve walking and movement in people with early to moderate Parkinson's disease. If you have trouble with your gait or balance, this study may offer a supervised exercise program to help manage symptoms.
Tel AvivAges Any age - NCT07100171RecruitingEarly Phase 1
GM101 injection for advanced Parkinson's disease
This trial tests an investigational gene therapy injection called GM101 for people with advanced Parkinson's disease whose symptoms are not well controlled by standard medications. The study will see if this treatment can help improve movement and quality of life.
ChangshaAges 40–70 - NCT06982638Recruiting
Speeding up walking in Parkinson's with brain stimulation
This trial tests if a special type of brain stimulation (called TMS) can help people with Parkinson's disease who experience freezing of gait—when your feet feel stuck to the floor. The goal is to see if this treatment can improve walking and reduce those freezing episodes.
Charleston, South CarolinaAges 50–80 - NCT06891781Recruiting
Adaptive deep brain stimulation for Parkinson's
This study tests a new type of deep brain stimulation (DBS) that adapts to your brain activity in real time. It is for people with Parkinson's disease whose symptoms are not well managed by medication and who are already candidates for DBS surgery.
MonzaAges 18 years+ - NCT06874803Recruiting
Acupuncture and moxibustion for early Parkinson's motor symptoms
This trial tests whether acupuncture and moxibustion can help improve movement symptoms in people with early to moderate Parkinson's disease. It is designed to see if adding these treatments to your regular care offers extra benefits.
Beijing, Beijing MunicipalityAges 30–80 - NCT06804642Recruiting
Spinal cord stimulation for Parkinson's walking rehab
This study tests whether a mild electrical stimulation applied to the skin on your lower back (called spinal cord stimulation) can help improve walking and movement in people with Parkinson's disease. It involves some rehabilitation exercises, and the goal is to see if this combination can help you move better.
Louisville, KentuckyAges 18–80 - NCT06753331RecruitingPhase 1/Phase 2
Study of DSP-1083 for Parkinson's disease
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
Lexington, KentuckyAges 40–72 - NCT06701955Recruiting
Reliability of a Fluctuation Scale in Parkinson's
This study tests how consistently a new scale measures 'on-off' fluctuations in Parkinson's disease. If you experience motor fluctuations (times when your symptoms change) and are on stable medication, you may help validate this tool.
GrenobleAges 30–75 - NCT06671600Recruiting
Osteopathic treatment for sleep in Parkinson's disease
This study tests if gentle hands-on treatments (osteopathic manipulative medicine) can improve sleep quality for people with Parkinson's disease. You will wear a Fitbit and a ring to track your sleep, and receive the treatments over several sessions.
Old Westbury, New YorkAges Any age - NCT06634641RecruitingPhase 4
Clozapine and immune function in Parkinson's disease
This trial tests whether clozapine, a medication for psychosis in Parkinson's disease, affects the immune system. It involves regular blood monitoring to help keep patients safe.
SalouëlAges 18 years+ - NCT06565195RecruitingPhase 1
Study of an investigational drug for Parkinson's disease
This study tests an experimental drug called LY3962681 in two groups: healthy volunteers and people with Parkinson's disease. The goal is to see if the drug is safe and how the body handles it, which may lead to future treatments for Parkinson's.
Englewood, ColoradoAges 30–80 - NCT06561919Recruiting
Speech and language study during brain stimulation treatment
This is an extra part of the STIMPulseControl study that focuses on speech. It looks at how the brain stimulation treatment affects your ability to speak clearly and communicate.
CologneAges 18–70 - NCT06231563RecruitingPhase 2
Ketamine for depression in veterans with Parkinson's
This study tests if ketamine can help treat depression in veterans with Parkinson's disease. It involves several in-person and remote visits, and you will need to avoid certain medications and cannabis for a short time before and during some visits.
San Francisco, CaliforniaAges 40–80 - NCT06087926Recruiting
TMS for apathy in Parkinson's disease
This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help improve apathy, or loss of motivation, in people with Parkinson's disease. You must have had symptoms for at least 4 years and be on stable Parkinson's medications.
Chapel Hill, North CarolinaAges 55–80 - NCT06002581Recruiting
Using brain stimulation to slow Parkinson's disease progression
This study tests if a non-invasive brain stimulation technique called rTMS (repetitive Transcranial Magnetic Stimulation) can slow down Parkinson's disease by improving slow-wave sleep. It aims to help people with mild to moderate Parkinson's who are stable on their medication.
Shanghai, Shanghai MunicipalityAges 50–80
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson disease (disorder)?
- Yes. Clin2 currently lists 496 recruiting parkinson disease (disorder) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson disease (disorder) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson disease (disorder) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.